Ginkgo Bioworks Holdings, Inc. (DNA) Guidance & Earnings Results
On 2026-08-05 Ginkgo Bioworks Holdings, Inc. reaffirmed guidance: "Expected total cash burn ($150)-($125) million in…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
DNAGinkgo Bioworks Holdings, Inc.Follow DNA — free
—
Price chart with a free account
- Market cap
- 672.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 5 Aug 26 | Reaffirmed | Expected total cash burn ($150)-($125) million in 2026 · full year |
| 7 May 26 | Reaffirmed | Total cash burn $(150)-$(125) million in 2026 · full year |
| 6 Nov 25 | Reaffirmed | FY2025 total revenue $167-$187M; Cell Engineering $117-$137M; Biosecurity at least $40M · full year |
| 7 Aug 25 | Reaffirmed | FY25 total revenue $167-187M; Cell Engineering $117-137M; Biosecurity at least $40M · full year |
Ginkgo Bioworks Holdings, Inc. — questions
- What guidance did Ginkgo Bioworks Holdings, Inc. give?
- On 2026-08-05: "Expected total cash burn ($150)-($125) million in 2026"
- When does Ginkgo Bioworks Holdings, Inc. report earnings?
- Ginkgo Bioworks Holdings, Inc.'s next earnings report is expected on 2026-11-05.
Every figure on this page comes from Ginkgo Bioworks Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.